Skip to main content
. 2014 Oct 21;12:291. doi: 10.1186/s12967-014-0291-1

Figure 3.

Figure 3

OS improvement in the treatment of advanced mHNC adding anti-EGFR MoAbs to chemotherapy [ 74 , 76 ].